Editas Medicine

Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.

Gene Editing

CRISPR Technology

Genomic Medicine

Clinical Research

Rare Diseases

Cambridge, Middlesex County

201-500

2013年設立（13年目）

ハイブリッド

Public

企業価値

$1.2B

累計調達額

$300M

EDIT

$3.11

ウェブサイト

採用ページ

ブログ

Editas Medicineの求人

求人0件

現在募集中の求人はありません

募集終了した求人

1件のポジション

Join Our Team

Remote

終了 1ヶ月前

製品・サービス

reni-cel

Gene Therapy

EDIT-101

Gene Therapy

EDIT-301

Cell Therapy

CRISPR Gene Editing Platform

Technology Platform

EDIT-201

Gene Therapy

In Vivo Gene Editing Medicines

Gene Therapy

EDIT-103

Gene Therapy

In Vivo Gene Editing Services

R&D Services

CRISPR/Cas Gene Editing Platform

Platform Technology

Ex Vivo Cell Engineering

R&D Services

Ex Vivo Gene Editing Services

Research Services

Engineered Natural Killer (eNK) Cell Platform

Cell Therapy

EDIT-401

Gene Therapy

経営陣

Charlene Stern

Executive Vice President & General Counsel

Kevin Bitterman

Interim President

DRL

David R. Liu

Founder

Feng Zhang

Founder

類似企業

BioNTech

Develops immunotherapies and vaccines, particularly for cancer and infectious diseases.

Mainz, Rhineland-Palatinate

1,001-5,000名

Public

企業価値 $21.7B

88件の求人

Regeneron

Focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations int...

Eastview, Mount Pleasant

10,001+名

Public

企業価値 $76B

453件の求人

CRISPR Therapeutics

CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in…

Zug, Canton of Zug

201-500名

Public

企業価値 $2.9B

13件の求人

Boston Scientific

Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.

Marlborough, Massachusetts

10,001+名

Public

企業価値 $58B

1,499件の求人

Xaira

AI for drug discovery

San Francisco, CA

51-200名

Private

企業価値 2.1B